Home > PJ > News / Daily News

Return to PJ Online Home Page
The Pharmaceutical Journal Vol 267 No 7156 p39-44
July 14, 2001

News summary


Sales warning for retail pharmacies

MOST companies in the community pharmacy sector will see sales stagnate or decline over the next 12 months, according to a new report. An analysis of 1,000 United Kingdom companies in the “retail chemists industry” predicts an overall sales growth of 5 per cent, but says that only 41 per cent of companies will share in that growth. A further 42 per cent are predicted to see stagnant sales and 17 per cent to see a drop in sales.

“Profit predictor edition 2001: retail chemists” says that as competition intensifies, companies will need to get a better grasp of their costs to improve their profitability. Loss-making companies should adopt an emergency consolidation plan, improving profitability by reducing sales, overheads and staff. Stagnating companies should tweak their businesses by taking a critical look at non-essential costs. Successful companies should expand, increasing their profits through further sales growth.

The report costs £450. Further details from Plimsoll Publishing on 01642 257800.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal